Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fatheya Al Khaja"'
Autor:
Rabah Almahmoud, Amal Hussein, Fatheya Al Khaja, Ahmed Farrag Soliman, Hany Dewedar, Zainab Al Shareef, Sarah Mathai
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background β-Thalassemia major (BTM) is one of the most common hereditary anemias worldwide. Patients suffer from iron overload that results from repeated blood transfusion This in turn leads to multiple organ damage and endocrinopathies. T
Externí odkaz:
https://doaj.org/article/829b79ec6eb641bc8a4fd7a0fcbfda75
Autor:
Rabah Almahmoud, Amal Hussein, Fatheya Al Khaja, Ahmed Farrag Soliman, Hany Dewedar, Sarah Mathai
Publikováno v:
Advances in Biomedical and Health Sciences, Vol 1, Iss 4, Pp 237-241 (2022)
Background: β-thalassemia major (BTM) is one of the hereditary anemias that is inherited as autosomal recessive. It is complicated by iron overload in different organs including the heart, liver, and endocrine glands. This study aimed to look at the
Externí odkaz:
https://doaj.org/article/44e1338c515f47b2b9ea4e1e73e0a880
Publikováno v:
Journal of Blood Disorders & Transfusion.
Blood transfusion to treat β-Thalassemia Intermedia (BTI) during pregnancy carries a major risk of eliciting alloantibodies that cause hemolysis, which can progress to severe refractory hemolytic anemia. Moreover, autoimmune hemolytic anemia can dev
Autor:
Maisan Lateef Bakir, Fatheya Al-Khaja, Hany Dewedar, Ahmed Mohamed Kadhim, Khawla Belhoul, Mohamed Salah Eldin
Publikováno v:
Annals of Saudi Medicine, Vol 33, Iss 1, Pp 18-21 (2013)
BACKGROUND AND OBJECTIVES: Authors and team members of the Dubai Thalassemia Centre obtained data on the prevalence of iron overload complications among patients with β-thalassemia major (β-TM) and compared it to international data to improve patie
Autor:
Hany Dewedar, Ahmed Farrag, Najmelddin Eltayb, Nishi Susan Oommen, Fatheya Al-Khaja, Maisam L Bakir, Khawla Mohd Belhoul
Publikováno v:
Blood. 122:2263-2263
The management cost of iron overload is rising with the introduction of magnetic resonance T2-star (T2*), oral iron chelation and combination therapy. The aim of this study was to develop and validate a simple and cheap clinical risk assessment model